Absolute oxygen-guided radiation therapy improves tumor control in three preclinical tumor models
CONCLUSION: This study confirms that EPROI locates resistant tumor hypoxic regions for radiation boost, increasing clonogenic LTCP, with potential enhanced therapeutic index in three tumor types. Preclinical absolute EPROI may provide correction for clinical hypoxia images using additional clinical physiologic MRI.PMID:37904839 | PMC:PMC10613495 | DOI:10.3389/fmed.2023.1269689
Source: Cancer Control - Category: Cancer & Oncology Authors: Inna Gertsenshteyn Boris Epel Mihai Giurcanu Eugene Barth John Lukens Kayla Hall Jenipher Flores Martinez Mellissa Grana Matthew Maggio Richard C Miller Subramanian V Sundramoorthy Martyna Krzykawska-Serda Erik Pearson Bulent Aydogan Ralph R Weichselbaum Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Fibrosarcoma | Radiation Therapy | Squamous Cell Carcinoma | Study